Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Antihypertensive Therapies in H-type Hypertension (Feasibility)
NCT02817503Phase 4Unknown
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Dec 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of enalapril + folic acid in hypertension (HTN) and hyperhomocysteinemia (3 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoint: Achieved mean blood pressure levels at 6 months. Status: unknown.
02
Drugs
enalapril + folic acid
03
Conditions
hypertension (HTN)hyperhomocysteinemia
Beyond the preview
Go deeper on NCT02817503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02817503.